India, June 26 -- Hilleman Laboratories,a global research and development organizationfocused on delivering high-impact and affordable vaccines, has announced that it has entered into a collaboration with Bharat Biotech International Ltd. (BBIL), a leading vaccine and biotechnology company in India for further development, manufacturing and commercialization of its next-generation Oral Cholera Vaccine, Hillchol(R).

This collaboration will strengthen the ability of both organizations towards prevention of Cholera through rapid and cost-effective deployment of vaccine doses in low and middle-income countries.

Cholerais an acute diarrheal infectioncausedbyVibrio Choleraeand has been responsible for seven pandemics till date. Cholera is a p...